Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

16.12
-1.0600-6.17%
Post-market: 16.120.00000.00%19:30 EDT
Volume:2.53M
Turnover:41.55M
Market Cap:864.52M
PE:-3.66
High:18.14
Open:17.42
Low:16.02
Close:17.18
52wk High:24.27
52wk Low:9.54
Shares:53.63M
Float Shares:40.15M
Volume Ratio:3.39
T/O Rate:6.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:1.93
PE(LYR):-2.76

Loading ...

Avalo Therapeutics Inc - to Pay $2.25 Mln to Securityholders' Representative Within Five Business Days of April 26, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 28

Avalo Therapeutics Inc - Enters Milestone Buyout Option Agreement on April 26, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 28

Avalo buys option to cut AlmataBio milestone payment to $5.13 million

Reuters
·
Apr 28

Press Release: Avalo Therapeutics Purchases Optional Milestone Buyout

Dow Jones
·
Apr 28

Avalo Therapeutics announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 11

Avalo CMO Doyle Mittie disposes 3,970 shares worth $71,511

Reuters
·
Apr 09

Avalo CFO Christopher Sullivan disposes AVTX shares worth $0.3 million under 10b5-1 plan

Reuters
·
Apr 04

Avalo CMO Mittie Doyle disposes Avalo Therapeutics common shares worth $0.01 million

Reuters
·
Apr 04

Avalo Therapeutics board changes; Goldman and Chan decline to seek re-election at FY2026 annual meeting

Reuters
·
Mar 28

Avalo Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $40 From $25

THOMSON REUTERS
·
Mar 25

U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources

Reuters
·
Mar 25

Avalo Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 23

Avalo Therapeutics Publishes Corporate Presentation on Abdakibart IL-1β Therapy for Hidradenitis Suppurativa

Reuters
·
Mar 23

Avalo Therapeutics posts lower-than-expected 2025 net loss

Reuters
·
Mar 23

Avalo Therapeutics FY2025 net loss widens 123% to USD 78 million, R&D expenses rise 105% to USD 50 million

Reuters
·
Mar 23

Avalo Therapeutics FY Operating Expenses USD 72.984 Million

THOMSON REUTERS
·
Mar 23

Press Release: Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates

Dow Jones
·
Mar 23

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Avalo Therapeutics (AVTX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Mar 19